CWCBExpo NYC 2019

Eric Hollander
Director of the Autism and Obsessive Compulsive Spectrum Program
Montefiore Medical Center and the Albert Einstein College of Medicine


Dr. Hollander is a Professor of Psychiatry and Behavioral Sciences at the Albert Einstein College of Medicine and Director of the Autism and Obsessive Compulsive Spectrum Program, and the Anxiety and Depression Program, at Montefiore Medical Center and the Albert Einstein College of Medicine. Previously he served as the Esther and Joseph Klingenstein Professor and Chair of Psychiatry at the Mount Sinai School of Medicine and was Director of the Seaver and NY Autism Center of Excellence in New York City. Before then he served as Associate Professor of Clinical Psychiatry at the Columbia University College of Physicians and Surgeons in New York. Dr. Hollander has served as the principal investigator for a number of federal grants, including the NIH Greater New York Autism Center of Excellence; the NIMH Research Training Grant in Psychopharmacology and Outcomes Research; the DOD CBDV in ASD treatment study; and FDA funded multicenter treatment trials of pediatric body dysmorphic disorder, autism and Prader Willi Syndrome. He was the principal investigator of the autism Clinical Trials Network, and Chair of the eight centers NIH STAART Autism Steering Committee. He is involved in research on the neuropharmacology, neuropsychiatry, functional imaging, and treatment of obsessive-compulsive disorder, impulsive-aggressive disorders, obsessive-compulsive-related disorders such as body dysmorphic disorder, pathological gambling; Prader Willi Syndrome, and autism. Dr. Hollander has received a Research Scientist Development Award from the National Institute of Mental health to investigate the psychobiology of obsessive-compulsive and related disorders. He has received orphan drug grants from the Food and Drug Administration to study new treatments for body dysmorphic disorder, child/adolescent autism, and adult autism. He has received several grants including one from the Department of Defense to study CBDV in autism spectrum disorder.

Sessions :